Literature DB >> 27265700

Psychosis as a continuous phenotype in the general population: the thin line between normality and pathology.

Anthony S David1, Olesya Ajnakina1.   

Abstract

Entities:  

Year:  2016        PMID: 27265700      PMCID: PMC4911757          DOI: 10.1002/wps.20327

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  9 in total

1.  Causes and consequences of duration of untreated psychosis in schizophrenia.

Authors:  R J Drake; C J Haley; S Akhtar; S W Lewis
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

2.  Whither DSM-V?

Authors:  Allen Frances
Journal:  Br J Psychiatry       Date:  2009-11       Impact factor: 9.319

3.  Why we need more debate on whether psychotic symptoms lie on a continuum with normality.

Authors:  A S David
Journal:  Psychol Med       Date:  2010-02-11       Impact factor: 7.723

4.  Impact of childhood adversities on specific symptom dimensions in first-episode psychosis.

Authors:  O Ajnakina; A Trotta; E Oakley-Hannibal; M Di Forti; S A Stilo; A Kolliakou; P Gardner-Sood; F Gaughran; A S David; P Dazzan; C Pariante; V Mondelli; C Morgan; E Vassos; R M Murray; H L Fisher
Journal:  Psychol Med       Date:  2015-09-18       Impact factor: 7.723

5.  Psychosis as a transdiagnostic and extended phenotype in the general population.

Authors:  Jim van Os; Uli Reininghaus
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

6.  Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase.

Authors:  Lucia R Valmaggia; Majella Byrne; Fern Day; Matthew R Broome; Louise Johns; Oliver Howes; Paddy Power; Steven Badger; Paolo Fusar-Poli; Philip K McGuire
Journal:  Br J Psychiatry       Date:  2015-06-04       Impact factor: 9.319

7.  Schizophrenia-like topological changes in the structural connectome of individuals with subclinical psychotic experiences.

Authors:  Mark Drakesmith; Karen Caeyenberghs; Anirban Dutt; Stanley Zammit; C John Evans; Abraham Reichenberg; Glyn Lewis; Anthony S David; Derek K Jones
Journal:  Hum Brain Mapp       Date:  2015-04-02       Impact factor: 5.038

8.  Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population.

Authors:  Hannah J Jones; Evie Stergiakouli; Katherine E Tansey; Leon Hubbard; Jon Heron; Mary Cannon; Peter Holmans; Glyn Lewis; David E J Linden; Peter B Jones; George Davey Smith; Michael C O'Donovan; Michael J Owen; James T Walters; Stanley Zammit
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

9.  Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study.

Authors:  Craig Morgan; Rudwan Abdul-Al; Julia M Lappin; Peter Jones; Paul Fearon; Morven Leese; Tim Croudace; Kevin Morgan; Paola Dazzan; Tom Craig; Julian Leff; Robin Murray
Journal:  Br J Psychiatry       Date:  2006-11       Impact factor: 9.319

  9 in total
  3 in total

1.  Disruptions in White Matter Maturation and Mediation of Cognitive Development in Youths on the Psychosis Spectrum.

Authors:  Catherine E Hegarty; Dietsje D Jolles; Eva Mennigen; Maria Jalbrzikowski; Carrie E Bearden; Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-12-27

2.  State-Dependent Functional Dysconnectivity in Youth With Psychosis Spectrum Symptoms.

Authors:  Eva Mennigen; Dietsje D Jolles; Catherine E Hegarty; Mohan Gupta; Maria Jalbrzikowski; Loes M Olde Loohuis; Roel A Ophoff; Katherine H Karlsgodt; Carrie E Bearden
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

3.  Urban Birth, Urban Living, and Work Migrancy: Differential Effects on Psychotic Experiences Among Young Chinese Men.

Authors:  Jeremy W Coid; Junmei Hu; Constantinos Kallis; Yuan Ping; Juying Zhang; Yueying Hu; Tianqiang Zhang; Rafael Gonzalez; Simone Ullrich; Peter B Jones; James B Kirkbride
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.